| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $80.8M | +14.9% |
| SG&A Expense | $21.5M | +10.5% |
| Operating Income | -$102.2M | -13.9% |
| Interest Expense | $1.9M | +185.2% |
| Pre-tax Income | -$102.0M | -13.0% |
| Income Tax | $19K | +112.9% |
| Net Income | -$102.0M | -13.2% |
| EPS (Basic) | -$2.93 | +34.6% |
| EPS (Diluted) | -$2.93 | +34.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.3M | +5.4% |
| Current Assets | $196.1M | +21.1% |
| Total Assets | $196.8M | +21.2% |
| Current Liabilities | $24.6M | +26.0% |
| Long-term Debt | $19.7M | +1.5% |
| Total Liabilities | $45.0M | +23.4% |
| Stockholders' Equity | $151.8M | +20.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.1M | -5.6% |
| Capital Expenditures | $7K | -88.9% |
| Investing Cash Flow | -$33.9M | -574.1% |
| Financing Cash Flow | $117.8M | +393.6% |
| Free Cash Flow | -$81.1M | -5.5% |